Cizzle Biotechnology Holdings plc (LSE: CIZ): CIZ1B biomarker test approved for clinical use in the USOptima Health plc (AIM: OPT): FY2026 trading update
16 Jun 2026
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
- Published:
16 Jun 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
3 -
Cizzle Biotechnology Holdings plc (LSE: CIZ): CIZ1B biomarker test approved for clinical use in the USOptima Health plc (AIM: OPT): FY2026 trading update